M Safi, PhD, is an experienced professional in new product development and analytical method development within the pharmaceutical and biotechnology sectors. Currently serving at Baxter International Inc. since 2024, M Safi also holds positions as a council member at NineSigma and GLG since 2020. Previous roles include CMC preclinical development at argenx and analytical project leader at The Janssen Pharmaceutical Companies of Johnson & Johnson and UCB. M Safi's expertise encompasses the development and validation of analytical methods for biological drugs, gene therapy physico-chemical method development, and extensive experience in mass spectrometry. Educational qualifications include a Doctor of Pharmacy from the University of Antwerp and University of Gent, and a Master of Science in Analytical Chemistry from the University of Tabriz.
This person is not in any teams
This person is not in any offices